G-BA

Germany's Gemeinsamer Bundesausschuss (G-BA) decided on Thursday to allow health insurers to cover four drugs that alleviate certain Long Covid symptoms. Previously, patients had to pay for these off-label uses themselves. The ruling eases access for the country's 74 million statutory insurees.